MktsMarkets

OptimizeRx Corporation
NASDAQ: OPRXKey statistics
OPRX News
Stories mentioning OPRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 19,844 | 32,239 | 26,067 | 29,195 | 21,928 | 32,316 | 21,309 | 18,812 |
| Cost of Goods Sold | 4,912 | 8,139 | 8,551 | 10,560 | 8,584 | 10,293 | 7,862 | 7,108 |
| Gross Profit | 14,932 | 24,100 | 17,516 | 18,635 | 13,344 | 22,023 | 13,447 | 11,704 |
| Operating Expenses | ||||||||
| Research & Development | 3,402 | 3,252 | ||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 15,532 | 15,466 | 15,446 | 15,458 | 18,389 | 22,009 | 15,453 | |
| Operating Income (Loss) | 396.00 | 8,556 | 2,050 | 3,189 | (2,102) | 3,634 | (8,562) | (3,749) |
| Interest Income | 77.00 | 84.00 | 91.00 | 90.00 | 88.00 | 96.00 | 107.00 | 106.00 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (644.00) | 7,460 | 1,049 | 1,713 | (3,272) | 2,207 | (9,941) | (5,096) |
| Tax Provision | (149.00) | 2,440 | 270.00 | 181.00 | (1,073) | 2,286 | (817.00) | (1,088) |
| Net Income (Loss) | (495.00) | 5,020 | 779.00 | 1,532 | (2,199) | (78.00) | (9,124) | (4,008) |
| Earnings Per Share (Basic) | (0.03) | 0.27 | 0.04 | 0.08 | (0.12) | 0.00 | (0.50) | (0.22) |
| Earnings Per Share (Diluted) | (0.03) | 0.26 | 0.04 | 0.08 | (0.12) | 0.00 | (0.50) | (0.22) |
| Weighted Average Shares Outstanding (Basic) | 18,762 | 18,555 | 18,576 | 18,511 | 18,471 | 18,293 | 18,324 | 18,258 |
| Weighted Average Shares Outstanding (Diluted) | 18,762 | 18,998 | 19,460 | 19,015 | 18,471 | 18,293 | 18,324 | 18,258 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About OPRX
OptimizeRx Corporation (NASDAQ: OPRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol OPRX. It last traded at $9.15 (Oct 23, 2026, 4:00 PM ET), up 0.8% on the day. That gives OptimizeRx a market capitalisation of $172.3M and a price-to-earnings ratio of 37.5.
Over the past 52 weeks OPRX has traded between $4.54 and $22.25.
Revenue for the quarter ended Mar 31, 2026 was $19.8M; a net loss of $495.0K. Revenue was down 9.5% from $21.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $19.8M | -$495.0K | -2.5% |
| Dec 31, 2025 | $32.2M | $5.0M | 15.6% |
| Sep 30, 2025 | $26.1M | $779.0K | 3.0% |
| Jun 30, 2025 | $29.2M | $1.5M | 5.2% |
From OptimizeRx’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…